- Ownership
- Activity
WX Stock Ownership Activity
WUXI PHARMATECH CAYMAN-ADR 13F holders
No value investing guru has made any change to the WUXI PHARMATECH CAYMAN-ADR (WX) position according to the gurus' latest SEC quarterly report(s).
Which gurus or hedge funds are buying WX now?
According to the latest SEC filing(s) WUXI PHARMATECH CAYMAN-ADR (WX) has not been purchased by any super investor.
To see more about who is investing in WUXI PHARMATECH CAYMAN-ADR (WX), please go to the WX ownership page.
2015 Q4
(1 result)
Reported price*: $43.21
2015 Q3
(1 result)
Reported price*: $43.21
2015 Q2
(1 result)
Reported price*: $41.54
2015 Q1
(1 result)
Reported price*: $38.78
2014 Q3
(1 result)
Reported price*: $35.02
2014 Q2
(1 result)
Reported price*: $32.86
2014 Q1
(1 result)
Reported price*: $31.37
2013 Q4
(1 result)
Reported price*: $38.38
2013 Q3
(1 result)
Reported price*: $27.40
9 of 9
Shares, change to shares, sold shares - split-adjusted.
Reported price - this doesn't represent the actual buy or sell price.
It is the split-adjusted price of the security as of the last day of the reported period.
Value or Price - If the security is completely sold out, we show the reported value (or price) prior to the actual period.